Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy.

Moisoiu V, Lourman R, Szulzewsky F, Kessler T, Collotta G, Porro A, Bertolini A, Singer F, Cimino PJ, Hertler C, Wick W, Reifenberger G, Holland EC, Sartori AA, Weller M, Wirsching HG

Open source

DOI: 10.1172/jci205299
Published: 2026 Aug 25
Container: The Journal of clinical investigation
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1172/jci205299,
  title = {Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy.},
  author = {Moisoiu V and Lourman R and Szulzewsky F and Kessler T and Collotta G and Porro A and Bertolini A and Singer F and Cimino PJ and Hertler C and Wick W and Reifenberger G and Holland EC and Sartori AA and Weller M and Wirsching HG},
  year = {2026},
  journal = {The Journal of clinical investigation},
  doi = {10.1172/jci205299},
  url = {https://doi.org/10.1172/jci205299}
}

RIS

TY  - JOUR
TI  - Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy.
AU  - Moisoiu V
AU  - Lourman R
AU  - Szulzewsky F
AU  - Kessler T
AU  - Collotta G
AU  - Porro A
AU  - Bertolini A
AU  - Singer F
AU  - Cimino PJ
AU  - Hertler C
AU  - Wick W
AU  - Reifenberger G
AU  - Holland EC
AU  - Sartori AA
AU  - Weller M
AU  - Wirsching HG
PY  - 2026
JO  - The Journal of clinical investigation
DO  - 10.1172/jci205299
UR  - https://doi.org/10.1172/jci205299
ER  -

APA

V, M., R, L., F, S., T, K., G, C., A, P., A, B., F, S., PJ, C., C, H., W, W., G, R., EC, H., AA, S., M, W., & HG, W. (2026). Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy.. The Journal of clinical investigation. https://doi.org/10.1172/jci205299

Source records

pubmed · retrieved 2026-09-25T00:33:43.395Z